Patients who were prescribed phentermine after losing fewer than 20 pounds while on a GLP-1 receptor agonist were more likely to lose weight 1 year after GLP-1 discontinuation than those who were not prescribed phentermine, recent findings show
The specific pattern, intensity, and duration of lifestyle intervention in the included studies was not clear
Among waitlist outcomes, transplant candidates among populations in medium/high CRE tertiles were associated with higher waitlist mortality (Medium HR 1.07, 95% CI 1.04-1.10, P 3 risk factors were associated with higher waitlist mortality, increased transplant probability and lower post-transplant patient/liver graft survival
Anxiety is not listed as a recognized adverse effect in the FDA prescribing information, and it did not occur at significantly higher rates in treatment groups compared to placebo during pivotal SURMOUNT trials
GLP-1 medication is an extra cost